Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
India Globalization Capital, Inc.
India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats.
IPO Date: June 1, 2006
Sector: Industrials
Industry: Trading Companies and Distributors
Market Cap: $28.49M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.08 | 5.49%
Avg Daily Range (30 D): $0.01 | 3.61%
Avg Daily Range (90 D): $0.01 | 3.80%
Institutional Daily Volume
Avg Daily Volume: .79M
Avg Daily Volume (30 D): 3.79M
Avg Daily Volume (90 D): 1.42M
Trade Size
Avg Trade Size (Sh.): 343
Avg Trade Size (Sh.) (30 D): 477
Avg Trade Size (Sh.) (90 D): 482
Institutional Trades
Total Inst.Trades: 85
Avg Inst. Trade: $2.55M
Avg Inst. Trade (30 D): $M
Avg Inst. Trade (90 D): $M
Avg Inst. Trade Volume: .23M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.15M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 473.34K
   
News
Jul 10, 2025 @ 5:00 PM
Cannabinoid Agonist Clinical Trial Pipeline Appear...
Source: Delveinsight
Jul 6, 2023 @ 12:03 PM
Why VBI Vaccines Are Trading Lower By Over 23%; He...
Source: Lisa Levin
Mar 20, 2023 @ 12:45 PM
IGC Announces Rebranding, Changes Name to IGC Pha...
Source: IGC Pharma, Inc.
Feb 15, 2023 @ 12:41 AM
IGC Reports Financial Results for Third Fiscal Qua...
Source: INDIA GLOBALIZATION CAPITAL INC.
Feb 8, 2023 @ 1:30 PM
IGC to be Featured in Feb. 10 Radius Research Inve...
Source: INDIA GLOBALIZATION CAPITAL INC.
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-.09 $-.09
Diluted EPS $-.09 $-.09
Revenue $ 1.27M $ $ 1.27M
Gross Profit $ .62M $ $ .62M
Net Income / Loss $ -7.12M $ $ -7.12M
Operating Income / Loss $ -7.45M $ $ -7.45M
Cost of Revenue $ .65M $ $ .65M
Net Cash Flow $ -.79M $ $ -.79M
PE Ratio    
Splits
Apr 19, 2013:   1:10